Government Affairs
Refine Search
article
In the wake of actions such as animal rights activists setting fire to the holiday home of Swiss drug major Novartis' chief executive Daniel Vasella's holiday home in Austria, and previously desecrating the graves of relatives, stealing the remains of his mother (The Pharma Letter August 11), Faculty of 1000 Biology members have throw their support behind a call to educate the public about animal research. 22 October 2009
Biotechnology
In the Business Environment Rating (BER) matrix for the fourth quarter of 2009, Malaysia has considerably improved its position in the Asia Pacific matrix, and is now ranked fifth out of the 15 key regional markets, according to a new report from Business Monitor International. 22 October 2009
Biotechnology
France Biotech, the French association of life science companies and its partners have unveiled proposals for the use of money raised by the French state's National Loan ("Grand Emprunt"). 20 October 2009
article
A key US Senate committee has endorsed a sweeping health care overhaul, gaining the support of an influential Republican. Senators voted by 14 votes to nine to pass the bill, with one Republican joining Democrats on the Senate Finance Committee in voting in favor. The proposal drafted by Chairman Max Baucus (Democrat, Montana) was designed to reduce costs, regulate insurers and expand coverage. 14 October 2009
Biotechnology
Plans for a unique 37 million ($58.9 million) Bioscience Campus in Stevenage, Hertfordshire - funded in partnership by the UK government, drug giant GlaxoSmithKline, The Wellcome Trust, Technology Strategy Board and East of England Development Agency - were announced yesterday by Business, Innovation and Skills Secretary, Lord Peter Mandelson. 14 October 2009
Pharmaceutical
In the past decade, the Chinese vaccine market tripled in scale. China has already become the world's largest vaccine producer and now has 28 vaccine companies, ranking number.1 around the globe, according to a new report added to the offerings of Reportlinker. 13 October 2009
Pharmaceutical
More than 30 groups representing consumer, labor and Medicare beneficiaries in the USA have joined a growing coalition urging Congress to support transparency requirements for pharmacy benefit managers (PBMs) in the health care reform proposals being considered by Congress. A total of 37 organizations wrote to Senate leaders to ask that Senator Maria Cantwell's (Democrat, Washington) amendment, approved by the Senate Finance Committee, be included in any final package voted on by the full Senate. 13 October 2009
Biotechnology
In Canada, Quebec Province Minister of Economic Development, Innovation and Export Trade, Clement Gignac, and Minister of Health and Social Services, Yves Bolduc have, unveiled the new Quebec Biopharmaceutical Strategy. Under this the Quebec government will earmark C$122.8 million ($117.8 million) over the next three years for the region's biopharmaceutical industry, in a move that was applauded by the industry. 12 October 2009
Pharmaceutical
US President-elect Donald Trump has named Johns Hopkins surgical oncologist Marty Makary as his nominee for Commissioner of the Food and Drug Administration (FDA), confirming recent speculation that he was the frontrunner for the position.
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze